The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of γH2AX levels in circulating tumor cells in patients treated with veliparib in combination with doxorubicin and cyclophosphamide in metastatic breast cancer.
Antoinette R. Tan
No relevant relationships to disclose
Deborah Toppmeyer
No relevant relationships to disclose
Serena Tsan-Lai Wong
No relevant relationships to disclose
Hongxia Lin
No relevant relationships to disclose
Murugesan Gounder
No relevant relationships to disclose
Rebecca Anne Moss
No relevant relationships to disclose
Mark N. Stein
No relevant relationships to disclose
Janice M. Mehnert
No relevant relationships to disclose
Sinae Kim
No relevant relationships to disclose
Alice P. Chen
No relevant relationships to disclose
Robert S. DiPaola
No relevant relationships to disclose